1
|
Garnier N, Berghout J, Zygmunt A, Singh D, Huang KA, Kantz W, Blankart CR, Gillner S, Zhao J, Roettger R, Saier C, Kirschner J, Schenk J, Atkins L, Ryan N, Zarakowska K, Zschüntzsch J, Zuccolo M, Müllenborn M, Man YS, Goodman L, Trad M, Chalandon AS, Sansen S, Martinez-Fresno M, Badger S, Walther van Olden R, Rothmann R, Lehner P, Tschohl C, Baillon L, Gumus G, Gross E, Stefanov R, Iskrov G, Raycheva R, Kostadinov K, Mitova E, Einhorn M, Einhorn Y, Schepers J, Hübner M, Alves F, Iskandar R, Mayer R, Renieri A, Piperkova A, Gut I, Beltran S, Matthiesen ME, Poetz M, Hansson M, Trollmann R, Agolini E, Ottombrino S, Novelli A, Bertini E, Selvatici R, Farnè M, Fortunato F, Ferlini A. Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe. PLoS One 2023; 18:e0293503. [PMID: 37992053 PMCID: PMC10664952 DOI: 10.1371/journal.pone.0293503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 10/03/2023] [Indexed: 11/24/2023] Open
Abstract
Since 72% of rare diseases are genetic in origin and mostly paediatrics, genetic newborn screening represents a diagnostic "window of opportunity". Therefore, many gNBS initiatives started in different European countries. Screen4Care is a research project, which resulted of a joint effort between the European Union Commission and the European Federation of Pharmaceutical Industries and Associations. It focuses on genetic newborn screening and artificial intelligence-based tools which will be applied to a large European population of about 25.000 infants. The neonatal screening strategy will be based on targeted sequencing, while whole genome sequencing will be offered to all enrolled infants who may show early symptoms but have resulted negative at the targeted sequencing-based newborn screening. We will leverage artificial intelligence-based algorithms to identify patients using Electronic Health Records (EHR) and to build a repository "symptom checkers" for patients and healthcare providers. S4C will design an equitable, ethical, and sustainable framework for genetic newborn screening and new digital tools, corroborated by a large workout where legal, ethical, and social complexities will be addressed with the intent of making the framework highly and flexibly translatable into the diverse European health systems.
Collapse
Affiliation(s)
- Nicolas Garnier
- Pfizer Inc., Collegeville, Pennsylvania, United States of America
| | - Joanne Berghout
- Pfizer Inc., Collegeville, Pennsylvania, United States of America
| | - Aldona Zygmunt
- Pfizer Inc., Collegeville, Pennsylvania, United States of America
| | - Deependra Singh
- Pfizer Inc., Collegeville, Pennsylvania, United States of America
| | - Kui A. Huang
- Pfizer Inc., Collegeville, Pennsylvania, United States of America
| | - Waltraud Kantz
- Pfizer Inc., Collegeville, Pennsylvania, United States of America
| | - Carl Rudolf Blankart
- KPM Center for Public Management and Swiss Institute for Translational and Entrepreneurial Medicine, University of Bern, Bern, Switzerland
| | - Sandra Gillner
- KPM Center for Public Management and Swiss Institute for Translational and Entrepreneurial Medicine, University of Bern, Bern, Switzerland
| | - Jiawei Zhao
- Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark
| | - Richard Roettger
- Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark
| | - Christina Saier
- Department of Neuropediatric and Muscle Disorders, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Jan Kirschner
- Department of Neuropediatric and Muscle Disorders, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Joern Schenk
- Takeda Pharmaceuticals International AG, Opfikon, Switzerland
| | - Leon Atkins
- Takeda Pharmaceuticals International AG, Opfikon, Switzerland
| | - Nuala Ryan
- Takeda Pharmaceuticals International AG, Opfikon, Switzerland
| | - Kaja Zarakowska
- Takeda Pharmaceuticals International AG, Opfikon, Switzerland
| | - Jana Zschüntzsch
- Department of Neurology, University Medical Center Goettingen, Göttingen, Germany
| | | | | | - Yuen-Sum Man
- Novo Nordisk Health Care AG, Switzerland &Novo Nordisk A/S, Kloten, Denmark
| | - Liz Goodman
- University College Dublin, National University of Ireland, Dublin, Ireland
| | | | | | | | | | | | | | - Robert Rothmann
- Research Institute AG & Co KG, Digital Human Rights Center, Wien, Austria
| | - Patrick Lehner
- Research Institute AG & Co KG, Digital Human Rights Center, Wien, Austria
| | - Christof Tschohl
- Research Institute AG & Co KG, Digital Human Rights Center, Wien, Austria
| | | | | | | | - Rumen Stefanov
- Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria
- Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria
| | - Georgi Iskrov
- Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria
- Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria
| | - Ralitsa Raycheva
- Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria
- Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria
| | - Kostadin Kostadinov
- Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria
- Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria
| | - Elena Mitova
- Bulgarian Association for Promotion of Education and Science, Institute for Rare Disease, Plovdiv, Bulgaria
| | | | | | - Josef Schepers
- Berlin Institute of Health (at) Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Miriam Hübner
- Berlin Institute of Health (at) Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Frauke Alves
- Translational Molecular Imaging, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany
- Clinic of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany
- Institute for Diagnostic and Interventional Radiology, University Medical Center, Göttingen, Germany
| | - Rowan Iskandar
- Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel), Bern, Switzerland
| | | | | | - Aneta Piperkova
- Bulgarian Association for Personalized Medicine, Sofia, Bulgaria
| | - Ivo Gut
- Centro Nacional de Analisis Genomico, CNAG, Barcelona, Spain
| | - Sergi Beltran
- Centro Nacional de Analisis Genomico, CNAG, Barcelona, Spain
| | | | - Marion Poetz
- Department of Strategy and Innovation, Copenhagen Business School, Copenhagen, Denmark
| | | | | | | | | | | | | | - Rita Selvatici
- Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - Marianna Farnè
- Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - Fernanda Fortunato
- Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - Alessandra Ferlini
- Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| |
Collapse
|
3
|
Beck S, LaFlamme M, Bergenholtz C, Bogers M, Brasseur TM, Conradsen ML, Crowston K, Di Marco D, Effert A, Filiou D, Frederiksen L, Gillier T, Gruber M, Haeussler C, Hoisl K, Kokshagina O, Norn MT, Poetz M, Pruschak G, Pujol Priego L, Radziwon A, Ruser A, Sauermann H, Shah SK, Suess-Reyes J, Tucci CL, Tuertscher P, Vedel JB, Verganti R, Wareham J, Xu SM. Examining Open Innovation in Science (OIS): what Open Innovation can and cannot offer the science of science. Innovation 2021. [DOI: 10.1080/14479338.2021.1999248] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- Susanne Beck
- Open Innovation in Science Center, Ludwig Boltzmann Gesellschaft, Vienna, Austria
- Department of Strategy and Innovation, Copenhagen Business School, Frederiksberg, Denmark
| | - Marcel LaFlamme
- Open Research, Public Library of Science, San Francisco, CA, USA
| | | | - Marcel Bogers
- Garwood Center for Corporate Innovation, Haas School of Business, University of California Berkeley, Berkeley, CA, USA
| | - Tiare-Maria Brasseur
- Open Innovation in Science Center, Ludwig Boltzmann Gesellschaft, Vienna, Austria
- Department of Strategy and Innovation, Copenhagen Business School, Frederiksberg, Denmark
| | | | - Kevin Crowston
- School of Information Studies, Syracuse University, Syracuse, NY, USA
| | | | - Agnes Effert
- Open Innovation in Science Center, Ludwig Boltzmann Gesellschaft, Vienna, Austria
| | - Despoina Filiou
- Department for Strategy and Marketing, The Open University Business School, Milton Keynes, UK
| | - Lars Frederiksen
- Department of Management, Aarhus BSS, Aarhus University, Aarhus, Denmark
| | - Thomas Gillier
- Department of Management, Technologies and Strategies, Grenoble Ecole de Management, Grenoble, France
| | - Marc Gruber
- College of Management of Technology, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - Carolin Haeussler
- School of Business, Economics and Information Systems, University of Passau, Passau, Germany
| | - Karin Hoisl
- Department of Strategy and Innovation, Copenhagen Business School, Frederiksberg, Denmark
- Business School, University of Mannheim, Mannheim, Germany
| | - Olga Kokshagina
- EDHEC Business School, 24 Av. Gustave Delory, 59100 Roubaix, France
| | - Maria-Theresa Norn
- Danish Centre for Studies on Research and Research Policy, Department of Political Science, Aarhus Bss, Aarhus University, Aarhus C, Denmark
| | - Marion Poetz
- Open Innovation in Science Center, Ludwig Boltzmann Gesellschaft, Vienna, Austria
- Department of Strategy and Innovation, Copenhagen Business School, Frederiksberg, Denmark
| | - Gernot Pruschak
- Business School, Bern University of Applied Sciences, Bern, Switzerland
| | | | - Agnieszka Radziwon
- Garwood Center for Corporate Innovation, Haas School of Business, University of California Berkeley, Berkeley, CA, USA
- Department of Business Development and Technology, Aarhus BSS, Aarhus University, Herning, Denmark
| | - Alexander Ruser
- Department of Sociology & Social Work, University of Agder, Kristiansand, Norway
| | | | - Sonali K. Shah
- Department of Business Administration, Gies College of Business, University of Illinois at Urbana-Champaign, Champaign, IL, USA
| | - Julia Suess-Reyes
- Open Innovation in Science Center, Ludwig Boltzmann Gesellschaft, Vienna, Austria
- Department of Strategy and Innovation, Copenhagen Business School, Frederiksberg, Denmark
| | - Christopher L. Tucci
- Imperial College Business School, Imperial College London, South Kensington Campus, London, UK
| | - Philipp Tuertscher
- School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
| | - Jane Bjørn Vedel
- Department of Organization, Copenhagen Business School, Frederiksberg, Denmark
| | - Roberto Verganti
- House of Innovation, Stockholm School of Economics, Stockholm, Sweden
| | | | - Sunny Mosangzi Xu
- Department of Food and Resource Economics, University of Copenhagen, Frederiksberg, Denmark
| |
Collapse
|